IRIS
SAMBATARO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.004
AS - Asia 1.051
EU - Europa 485
SA - Sud America 222
Continente sconosciuto - Info sul continente non disponibili 184
AF - Africa 18
OC - Oceania 1
Totale 3.965
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.954
SG - Singapore 350
IT - Italia 232
HK - Hong Kong 196
CN - Cina 184
BR - Brasile 164
BD - Bangladesh 122
VN - Vietnam 111
DE - Germania 63
FR - Francia 55
AR - Argentina 27
CA - Canada 27
IE - Irlanda 24
GB - Regno Unito 20
IN - India 19
AT - Austria 18
ID - Indonesia 16
NL - Olanda 16
SE - Svezia 14
EC - Ecuador 12
MX - Messico 12
FI - Finlandia 10
TR - Turchia 10
IQ - Iraq 8
PL - Polonia 7
CO - Colombia 6
ES - Italia 6
RU - Federazione Russa 6
ZA - Sudafrica 6
CL - Cile 5
JP - Giappone 5
MA - Marocco 5
AZ - Azerbaigian 4
CR - Costa Rica 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
IL - Israele 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
UA - Ucraina 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.781
Salva come PNG Salva come JPEG
Città #
Dallas 1.214
Hong Kong 195
San Jose 173
Singapore 150
Ashburn 109
Ho Chi Minh City 54
Chicago 44
The Dalles 44
Beijing 39
New York 35
Milan 31
Santa Clara 31
Dublin 24
Naples 20
São Paulo 16
Hanoi 13
Rome 13
Catania 12
Hillsboro 11
Los Angeles 11
Montreal 11
Frankfurt am Main 10
Buffalo 9
Helsinki 8
Istanbul 8
Orem 8
Palermo 8
Rio de Janeiro 8
Amsterdam 7
Boardman 7
Mexico City 7
Munich 7
Turin 7
Chennai 6
Council Bluffs 6
Düsseldorf 6
Quito 6
Biên Hòa 5
Boston 5
Brasília 5
Manchester 5
Misilmeri 5
Nuremberg 5
Porto Alegre 5
Vienna 5
Warsaw 5
Assago 4
Atlanta 4
Baghdad 4
Baku 4
Bologna 4
Brooklyn 4
Curitiba 4
Dhaka 4
Genoa 4
Guayaquil 4
Haiphong 4
Limburg an der Lahn 4
Seattle 4
Triggiano 4
Bari 3
Buenos Aires 3
Cagliari 3
Campinas 3
Casoria 3
Durban 3
Ealing 3
Guarulhos 3
Joinville 3
London 3
Messina 3
Miami 3
Mumbai 3
Resistencia 3
Ribeirão Preto 3
San Francisco 3
Tashkent 3
Varallo Pombia 3
Abbotsford 2
Alessandria 2
Avellino 2
Bandung 2
Belo Horizonte 2
Bogotá 2
Buritama 2
Can Tho 2
Chittagong 2
Corato 2
Cypress 2
Da Nang 2
Duque de Caxias 2
Florence 2
Fortaleza 2
General Roca 2
Hortolândia 2
Hải Dương 2
Ijuí 2
Independencia 2
Isidro Casanova 2
Jacksonville 2
Totale 2.567
Salva come PNG Salva come JPEG
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 282
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 257
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 236
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 187
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 90
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 87
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 85
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 83
Brain Metastasis in Endometrial Cancer: A Systematic Review 82
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 79
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 79
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 79
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 73
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 68
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 67
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 67
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 65
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 64
Prognostic Factors for Adrenocortical Carcinoma Outcomes 63
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 61
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 59
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 58
[Second-line chemotherapy and new drugs for ovarian carcinoma] 57
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 57
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 56
Chemotherapy extravasation: diagnosis, prevention and management 55
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 55
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 53
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 53
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 52
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 49
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 47
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 45
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 45
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 44
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 43
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 41
Bronchial carcinoid associated with Cushing's syndrome 39
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 38
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 36
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 31
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 27
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 24
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 22
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 22
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 22
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 21
Follow up of colorectal cancer 20
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 20
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 20
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 19
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 19
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 18
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 18
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 17
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 17
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 17
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 17
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 16
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 16
Trombosi e Cancro 16
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 16
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 16
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 16
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 15
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 15
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 15
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 15
Nutritional Status, Inflammatory Parameters and Cancer 14
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 14
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 14
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 13
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 13
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 13
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 13
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 13
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 13
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 12
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 12
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 12
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 11
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 11
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 11
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 11
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 11
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 10
Tromboembolismo in oncologia medica 10
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 10
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 9
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 8
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 8
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue 6
Magnesium and Cancer Immunotherapy: A Narrative Practical Review 4
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 4
Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora? 4
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases 3
Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? 3
Totale 3.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20263.269 103 282 1.122 256 230 221 124 253 195 170 200 113
2026/202781 56 25 0 0 0 0 0 0 0 0 0 0
Totale 3.965